Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lyssikatos Joseph P
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kintz Samuel
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144/A: Others
Enliven Therapeutics | 144/A: Others
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Enliven Therapeutics | 10-K: FY2024 Annual Report
Enliven Therapeutics | 8-K: Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Patel Anish
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hohl Benjamin
Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hohl Benjamin
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Enliven Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144